MK-2048 化学構造
分子量: 461.87




  • Compare Integrase Inhibitors
  • 研究分野



製品説明 MK-2048は、インテグラーゼ(IN)のための第二世代のインテグラーゼ阻害剤と2.6nMと1.5nMのIC50によるINR263Kです。
ターゲット IN INR263K
IC50 2.6 nM 1.5 nM [1]
In vitro試験 MK-2048 inhibits subtype B and subtype C integrase activities with IC50 of 75 nM and 80 nM, respectively. Disintegration is prevented by high concentrations of MK-2048 to a comparable extent with both subtype B and C enzymes. Mutation at the site of R263K slightly increases integrase susceptibility to MK-2048. G118R translates into a decrease in integrase activity and confers resistance to MK-2048. [2] MK-2048 inhibits S217H intasome with an IC50 of 900 nM. By contrast, MK2048 remains fully active against the N224H intasome with an IC50 of 25 nM. MK2048 displays substantially lower dissociation rates compared with raltegravir, another integrase inhibitor. [3] The subsequent selection of E138K partially restores replication capacity to approximately 13% of wt levels and increased resistance to MK-2048 to approximately 8-fold. MK-2048 is active against viruses resistant to RAL and EVG. Exposure to MK-2048 leads to the selection of G118R as a possible novel resistance mutation after 19 weeks. Continued pressure with MK-2048 subsequently leads to an additional substitution after 29 weeks at position E138K, within the IN gene. Although the G118R mutation alone confers only slight resistance to MK-2048 but not to RAL or EVG, its presence arouses a dramatic reduction in viral replication capacity compared to wild-type NL4-3. E138K both partially restores viral replication capacity and also contributes to increased levels of resistance against MK-2048. [4]
In vivo試験

プロトコル (参考用のみ)

細胞アッセイ: [4]

細胞株 PM1 cells
濃度 0.0256 nM to 2 μM
反応時間 72 hours
実験の流れ A total of 7.5×104 PM1 cells per well are infected with clonal NL4-3 virus containing the integrase mutations G118R, E138K, or G118R and E138K or with wild-type viruses (45 ng p24 virus per well) by spinoculation at 1,200 × g for 2 hours at 37 °C. Cells are washed twice to remove unbound virus and then resuspends in RPMI growth medium alone or containing various concentrations of MK-2048, ranging between 0.0256 nM and 2 μM. Experiments is performed, each in duplicate. Supernatant reverse transcriptase (RT) activity is measured at 72 hours postinfection as an indicator of virus replication. Data are normalized based on uninfected and no-drug controls included in each experiment. Viral replication capacity is determined in PM1 cells using the same methodology as that used to determine EC50s, by comparing levels of supernatant RT activity of each mutant virus to those of wild-type virus in the absence of MK-2048.

Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)

SpeciesMouseRatRabbitGuinea pigHamsterDogMonkeyBaboon
Weight (kg)
Body Surface Area (m2)0.0070.0250.
Km factor361285201220
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Rat dose (mg/kg) = mouse dose (22.4 mg/kg) ×  mouse Km(3)  = 11.2 mg/kg
rat Km(6)



Download MK-2048 SDF
分子量 461.87


CAS No. 869901-69-9
保管 3年-20℃
2年-80℃in solvent
別名 N/A
溶解度 (25°C) * In vitro DMSO 9 mg/mL (19.48 mM)
Water <1 mg/mL
Ethanol <1 mg/mL
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
化学名 Pyrazino[1',2':1,5]pyrrolo[2,3-d]pyridazine-4-carboxamide, 2-[(3-chloro-4-fluorophenyl)methyl]-8-ethyl-1,2,6,7,8,9-hexahydro-10-hydroxy-N,6-dimethyl-1,9-dioxo-, (6S)-



電話番号: +1-832-582-8158 Ext:3月曜日〜金曜日 9:00 AM–5:00 PM (米国中部標準時)


* 必須

Related インテグラーゼ 阻害剤

  • Cabotegravir (GSK744, GSK1265744)

    Cabotegravir (GSK744, GSK1265744)は1種の長継有効なHIVtインテグラーゼ(integrase)阻害剤で、広範なHIV亜型に作用します.。Cabotegravir (GSK744, GSK1265744)はHIV-1インテグラーゼ触媒の鎖転移反応を抑制します。このIC50値は3 nMです。臨床2期。

  • Tenofovir Alafenamide (GS-7340)

    Tenofovir Alafenamide (GS-7340)は1種のテノフォビル(tenofovir)のプロドラッグ(prodrug)です。tenofovirは1種の逆転写酵素(reverse transcriptase)の阻害剤で、HIVとB型肝炎の治療に作用します.。

  • Elvitegravir (GS-9137, JTK-303)

    Elvitegravir (GS-9137, JTK-303)は1種の不全ウイルス統合酵素阻害剤で、HIV-1IIIB、HIV-2EHOとHIV-2RODに作用する時に、IC50値は0.7、2.8と1.4nMそれぞれに分かれます。

  • Raltegravir (MK-0518)

    Raltegravir (MK-0518)はwtのための強力なインテグラーゼ(中で)ふさ移動阻害剤です、そして、S217Qは泡立つウイルス(PFV)の中で原型を作ります。 IC50 がそれぞれ 90 nM と 40 nMです。

    Features:The 1st approved human immunodeficiency virus type 1 (HIV-1) integrase inhibitor.

  • BMS-707035

    BMS-707035は、特定のHIV-Iインテグラーゼ(IN)阻害剤で、IC50 が15 nMになる。

  • Dolutegravir (GSK1349572)

    Dolutegravir (GSK1349572)は、2.7nMのIC50による次世代で2-金属結合性HIVインテグラーゼふさ移動阻害剤です。

    Features:A next-generation and two-metal-binding HIV integrase strand transfer inhibitor.

  • Maraviroc

    Maravirocは1種のMIP-1α、MIP-1βとRANTESのケモカイン受容体CCR5阻害剤です。IC50値は3.3 nM、7.2 nM と 5.2 nMそれぞれに分かれます。

  • Tenofovir Disoproxil Fumarate

    Tenofovir disoproxil fumarate belongs to nucleotide analogue reverse transcriptase inhibitors (nRTIs).

  • Zidovudine

    Zidovudine (ZDV)は1種のヌクレオシド類似体(nucleoside analog)逆転写酵素の阻害剤で、HIVの治療に使用します。


Tags: MK-2048を買う | MK-2048供給者 | MK-2048を購入する | MK-2048費用 | MK-2048生産者 | オーダーMK-2048 | MK-2048代理店
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID